US Stock MarketDetailed Quotes

EDIT Editas Medicine

Watchlist
  • 1.210
  • -0.020-1.63%
Close Dec 27 16:00 ET
  • 1.240
  • +0.030+2.47%
Post 19:59 ET
99.88MMarket Cap-0.48P/E (TTM)

Editas Medicine Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Editas Medicine Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 808.710K--
--2024/Q4-- / 36.022M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 808.710K--
--2024/Q4-- / 36.022M--
--2024/Q361.000K / 3.894M--
Aug 7, 20242024/Q2513.000K / 4.142M--
May 8, 20242024/Q11.135M / 7.296M--

Unlock Free Earnings Estimates

Editas Medicine Earnings Reports

  • Editas Medicine | 10-Q: Q3 2024 Earnings Report

    Nov 4 07:39 ET

  • Editas Medicine | 8-K: Editas Medicine Announces Third Quarter 2024 Results and Business Updates

    Nov 4 07:34 ET

  • Editas Medicine | 10-Q: Q2 2024 Earnings Report

    Aug 7 16:17 ET

  • Editas Medicine | 8-K: Editas Medicine Announces Second Quarter 2024 Results and Business Updates

    Aug 7 07:11 ET

    • Read more

    Trending US Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
    LTGHY
    +0.58%
    Halozyme Therapeutics
    HALO
    +0.21%
    AIRPORTS OF THAILAND PUBLIC CO UNSP ADR EACH REP 10 ORD SHS
    AIPUY
    0.00%
    YETI Holdings
    YETI
    -0.08%
    Dorian LPG
    LPG
    -0.25%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Dec 28, 2024

    Hold

    • Buy

      27.78%

    • Hold

      61.11%

    • Sell

      11.11%

    Price Target

    No Data

    Investment Theme Gene Editing
    Gene Editing
    Intraday-0.58%